Abstract
Brain death or pronouncing death by neurological criteria is a relatively new concept. The concept is based on the precept that irreversible loss of involuntary life-sustaining brain functions equates to the death of a living organism. The diagnosis of brain death is rooted in two indispensable tenets. The first is the irreversible loss of brain functions caused by a known metabolic or structural disease. The second tenet is that vital structures of the brain responsible for maintaining independent consciousness and independent life must be damaged beyond possible recovery. Determination of brain death is made by a careful and meticulous examination aimed at confirming three conditions: a state of unresponsive coma, absence of brain stem reflexes, and apnoea. Potential pitfalls accompany clinical examination, sometimes making the interpretation difficult and doubtful. These pitfalls range from poly-segmental spinal reflexes, local injury to cranial nerves, unidentified high spinal cord injury to the residual effect of the sedative, and neuromuscular blocking drugs. When uncertainty exists in the interpretation of clinical tests, ancillary tests are employed, as an adjunct to confirm the diagnosis of brain death. Ancillary tests too have limitations and clinicians should be aware of their pitfalls and relative reliability before arriving at any conclusions drawn from them.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cushing H. Some experimental and clinical observations concerning states of increased intracranial tension. Am J Med Sci. 1902;124:375–400.
Mollaret P, Goulon M. [The depassed coma (preliminary memoir)]. Rev Neurol. 1959;101:3–15.
Beecher HK, Adams RD, Barger AC, Curran WJ, et al. A definition of irreversible coma. JAMA. 1984;252(5):677–9.
Ave ALD, Bernat JL. Inconsistencies between the criterion and tests for brain death. J Intensive Care Med. 2018;35(8):772–80.
An appraisal of the criteria of cerebral death: a summary statement. JAMA. 1977;237(10):982.
Colleges A of MR. A code of practice for diagnosis and confirmation of death [Internet]. 2008. p. 41. https://www.aomrc.org.uk/reports-guidance/ukdec-reports-and-guidance/code-practice-diagnosis-confirmation-death/.
Greer DM, Shemie SD, Lewis A, Torrance S, Varelas P, Goldenberg FD, et al. Determination of brain death/death by neurologic criteria. JAMA. 2020;324(11):1078–97.
Spittler JF, Wortmann D, Düring MV, Gehlen W. Phenomenological diversity of spinal reflexes in brain death. Eur J Neurol. 2000;7(3):315–21.
Shlugman D. Abnormal pupillary activity in a brainstem-dead patient. Br J Anaesth. 2001;86(5):717–20. http://bja.oxfordjournals.org/content/86/5/717.
Posner JB, Saper CB, Plum F. Plum and Posner’s diagnosis of stupor and coma. 2007. p. 401. http://books.google.com/books?id=Otivdh2ZoVwC&printsec=frontcover.
Murphy PJ, Patel S, Marshall J. The effect of long-term, daily contact lens wear on corneal sensitivity. Cornea. 2001;20(3):264–9.
Wijdicks EFM. The diagnosis of brain death. N Engl J Med. 2001;344(16):1215–21.
Sawicki M, Bohatyrewicz R, Walecka A, Sołek-Pastuszka J, Rowiński O, Walecki J. CT angiography in the diagnosis of brain death. Pol J Radiol. 2014;79:417–21.
de Freitas GR, Andre C. Sensitivity of transcranial Doppler for confirming brain death: a prospective study of 270 cases. Acta Neurol Scand. 2006;113(6):426–32.
Kuo J-R, Chen C-F, Chio C-C, Chang C-H, Wang C-C, Yang C-M, et al. Time dependent validity in the diagnosis of brain death using transcranial Doppler sonography. J Neurol Neurosurg Psychiatry. 2006;77(5):646–9.
Huang AH. The hot nose sign. Radiology. 2005;235(1):216–7.
Munari M, Zucchetta P, Carollo C, Gallo F, Nardin MD, Marzola MC, et al. Confirmatory tests in the diagnosis of brain death: comparison between SPECT and contrast angiography. Crit Care Med. 2005;33(9):2068–73.
Heckmann JG, Lang CJG, Pfau M, Neundörfer B. Electrocerebral silence with preserved but reduced cortical brain perfusion. Eur J Emerg Med. 2003;10(3):241–3.
Buchner H, Schuchardt V. Reliability of electroencephalogram in the diagnosis of brain death. Eur Neurol. 1990;30(3):138–41.
Practice parameters for determining brain death in adults: (summary statement). Neurology. 1995;45(5):1012–4.
Sonoo M, Tsai-Shozawa Y, Aoki M, Nakatani T, Hatanaka Y, Mochizuki A, et al. N18 in median somatosensory evoked potentials: a new indicator of medullary function useful for the diagnosis of brain death. J Neurol Neurosurg Psychiatry. 1999;67(3):374–8.
Nakagawa TA, Ashwal S, Mathur M, Mysore M, Pediatrics S of CCM Section on Critical Care and Section on Neurology of American Academy of, Society CN. Guidelines for the determination of brain death in infants and children: an update of the 1987 task force recommendations. Pediatrics. 2011;128(3):e720–40.
Lewis A, Adams N, Chopra A, Kirschen MP. Organ support after death by neurologic criteria in pediatric patients. Crit Care Med. 2017;45(9):e916–24.
Lewis A, Adams N, Varelas P, Greer D, Caplan A. Organ support after death by neurologic criteria: results of a survey of US neurologists. Neurology. 2016;87(8):827–34.
Lewis A, Cahn-Fuller K, Caplan A. Shouldn’t dead be dead?: The search for a uniform definition of death. J Law Med Ethics. 2017;45(1):112–28.
Rosner F. Definition of death in Jewish law. N Y State J Med. 1983;83(7):973–8.
Loike J, Gillick M, Mayer S, Prager K, Simon JR, Steinberg A, et al. The critical role of religion: caring for the dying patient from an orthodox Jewish perspective. J Palliat Med. 2010;13(10):1267–71.
Biel S, Durrant J. Controversies in brain death declaration: legal and ethical implications in the ICU. Curr Treat Option Ne. 2020;22(4):12.
Hocker S, Schumacher D, Mandrekar J, Wijdicks EFM. Testing confounders in brain death determination: a new simulation model. Neurocrit Care. 2015;23(3):401–8.
Gortmaker SLP, Beasley CLM, Brigham LEM, Franz HGR, Garrison RNM, Lucas BAM, et al. Organ donor potential and performance. Crit Care Med. 1996;24(3):432–9.
Nathan HM, Jarrell BE, Broznik B, Kochik R, Hamilton B, Stuart S, et al. Estimation and characterization of the potential renal organ donor pool in Pennsylvania: report of the Pennsylvania Statewide Donor Study. Transplantation. 1991;51(1):142–9.
Salim A, Velmahos GC, Brown C, Belzberg H, Demetriades D. Aggressive organ donor management significantly increases the number of organs available for transplantation. J Trauma Inj Infect Crit Care. 2005;58(5):991–4.
Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. Transforming the “unacceptable” donor: outcomes from the adoption of a standardized donor management technique. J Hear Lung Transplant. 1995;14(4):734–42.
Schrader H, Hall C, Zwetnow NN. Effects of prolonged supratentorial mass expansion on regional blood flow and cardiovascular parameters during the Cushing response. Acta Neurol Scand. 1985;72(3):283–94.
Novitzky D, Rose AG, Cooper DKC. Injury of myocardial conduction tissue and coronary artery smooth muscle following brain death in the baboon. Transplantation. 1988;45(5):964–6.
Novitzky D, Wicomb WN, Cooper DKC, Rose AG, Reichart B. Prevention of myocardial injury during brain death by total cardiac sympathectomy in the Chacma baboon. Ann Thorac Surg. 1986;41(5):520–4.
Shivalkar B, Loon JV, Wieland W, Tjandra-Maga TB, Borgers M, Plets C, et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation. 2018;87(1):230–9.
Huang J, van Gelder JM. The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis. Neurosurgery. 2002;51(5):1101.
Skrifvars MB, Parr MJ. Incidence, predisposing factors, management and survival following cardiac arrest due to subarachnoid haemorrhage: a review of the literature. Scand J Trauma Resusc Emerg Med. 2012;20(1):75.
Sebening C, Hagl C, Szabo G, Tochtermann U, Strobel G, Schnabel P, et al. Cardiocirculatory effects of acutely increased intracranial pressure and subsequent brain death. Eur J Cardiothorac. 1995;9(7):360–72.
Venkateswaran RV, Patchell VB, Wilson IC, Mascaro JG, Thompson RD, Quinn DW, et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg. 2008;85(1):278–86.
Bugge JF. Brain death and its implications for management of the potential organ donor. Acta Anaesth Scand. 2009;53(10):1239–50.
Novitzky D, Wicomb WN, Rose AG, Cooper DKC, Reichart B. Pathophysiology of pulmonary edema following experimental brain death in the Chacma baboon. Ann Thorac Surg. 1987;43(3):288–94.
Solenski NJM, Haley ECJM, Kassell NFM, Kongable GR, Germanson TP, Truskowski LM, et al. Medical complications of aneurysmal subarachnoid hemorrhage. Crit Care Med. 1995;23(6):1007–17.
Masson F, Thicoïpe M, Latapie MJ, Maurette P. Thyroid function in brain-dead donors. Transplant Int. 1990;3(1):226–33.
Venkateswaran RV, Steeds RP, Quinn DW, Nightingale P, Wilson IC, Mascaro JG, et al. The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. Eur Heart J. 2009;30(14):1771–80.
Dimopoulou I, Tsagarakis S, Anthi A, Milou E, Ilias I, Stavrakaki K, et al. High prevalence of decreased cortisol reserve in brain-dead potential organ donors. Crit Care Med. 2003;31(4):1113–7.
Howlett TA, Keogh AM, Perry L, Touzel R, Rees LH. Anterior and posterior pituitary function in brain-stem-dead donors. Transplantation. 1989;47(5):828–33.
Birks EJ, Burton PBJ, Owen V, Mullen AJ, Hunt D, Banner NR, et al. Elevated tumor necrosis factor-α and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation. 2000;102(Suppl 3):III-352–8.
Pratschke J, Neuhaus P, Tullius SG. What can be learned from brain-death models? Transplant Int. 2005;18(1):15–21.
Bugge JF, Hartmann A, Osnes S, Bentdal O, Stenstrøm J. Immediate and early renal function after living donor transplantation. Nephrol Dial Transpl. 1999;14(2):389–93.
Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342(9):605–12.
Stangl M, Zerkaulen T, Theodorakis J, Illner W, Schneeberger H, Land W, et al. Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc. 2001;33(1–2):1284–5.
Avlonitis VS, Wigfield CH, Golledge HDR, Kirby JA, Dark JH. Early hemodynamic injury during donor brain death determines the severity of primary graft dysfunction after lung transplantation. Am J Transplant. 2007;7(1):83–90.
Rostron AJ, Avlonitis VS, Cork DMW, Grenade DS, Kirby JA, Dark JH. Hemodynamic resuscitation with arginine vasopressin reduces lung injury after brain death in the transplant donor. Transplantation. 2008;85(4):597–606.
Barklin A, Larsson A, Vestergaard C, Koefoed-Nielsen J, Bach A, Nyboe R, et al. Does brain death induce a pro-inflammatory response at the organ level in a porcine model? Acta Anaesth Scand. 2008;52(5):621–7.
Ball IM, Hornby L, Rochwerg B, Weiss MJ, Gillrie C, Chassé M, et al. Management of the neurologically deceased organ donor: a Canadian clinical practice guideline. CMAJ. 2020;192(14):E361–9.
Nakagawa K, Tang JF. Physiologic response of human brain death and the use of vasopressin for successful organ transplantation. J Clin Anesth. 2011;23(2):145–8.
Schnuelle P, Berger S, de Boer J, Persijn G, van der Woude FJ. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation. 2001;72(3):455–63.
Jeevanandam V. Triiodothyronine: spectrum of use in heart transplantation. Thyroid. 1997;7(1):139–45.
Mariot J, Jacob F, Voltz C, Perrier JF, Strub P. Intérêt de l’hormonothérapie associant triiodothyronine et cortisone chez le patient en état de mort cérébrale. Ann Françaises D’anesthésie Et De Réanimation. 1991;10(4):321–8.
Randell TT, Höckerstedt KAV. Triiodothyronine treatment in brain-dead multiorgan donors—a controlled study. Transplantation. 1992;54(4):736–7.
Novitzky D, Mi Z, Collins JF, Cooper DKC. Increased procurement of thoracic donor organs after thyroid hormone therapy. Seminars Thorac Cardiovasc Surg. 2015;27(2):123–32.
Israni AK, Zaun D, Hadley N, Rosendale JD, Schaffhausen C, McKinney W, et al. OPTN/SRTR 2018 annual data report: deceased organ donation. Am J Transplant. 2020;20(s1):509–41.
Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010;304(23):2620–7.
Miñambres E, Pérez-Villares JM, Chico-Fernández M, Zabalegui A, Dueñas-Jurado JM, Misis M, et al. Lung donor treatment protocol in brain dead-donors: a multicenter study. J Hear Lung Transplant. 2015;34(6):773–80.
Ware LB, Fang X, Wang Y, Sakuma T, Hall TS, Matthay MA. Selected contribution: mechanisms that may stimulate the resolution of alveolar edema in the transplanted human lung. J Appl Physiol. 2002;93(5):1869–74.
Kuecuek O, Mantouvalou L, Klemz R, Kotsch K, Volk HD, Jonas S, et al. Significant reduction of proinflammatory cytokines by treatment of the brain-dead donor. Transplant Proc. 2005;37(1):387–8.
Kotsch K, Ulrich F, Reutzel-Selke A, Pascher A, Faber W, Warnick P, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation. Ann Surg. 2008;248(6):1042–50.
McElhinney DB, Khan JH, Babcock WD, Hall TS. Thoracic organ donor characteristics associated with successful lung procurement. Clin Transplant. 2001;15(1):68–71.
Wood KE, Becker BN, McCartney JG, D’Alessandro AM, Coursin DB. Care of the potential organ donor. N Engl J Med. 2004;351(26):2730–9.
Niemann CU, Feiner J, Swain S, Bunting S, Friedman M, Crutchfield M, et al. Therapeutic hypothermia in deceased organ donors and kidney-graft function. N Engl J Med. 2015;373(5):405–14.
Busl KM, Greer DM. Pitfalls in the diagnosis of brain death. Neurocrit Care. 2009;11(2):276–87.
Hall CA, Chilcott RP. Eyeing up the future of the pupillary light reflex in neurodiagnostics. Diagnostics. 2018;8:19.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Verma, V., Verma, Y. (2022). Brain Death. In: Ganaw, A.E.A., Shaikh, N., Shallik, N.A., Marcus, M.A.E. (eds) Management of Subarachnoid Hemorrhage. Springer, Cham. https://doi.org/10.1007/978-3-030-81333-8_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-81333-8_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-81332-1
Online ISBN: 978-3-030-81333-8
eBook Packages: MedicineMedicine (R0)